Literature DB >> 23641591

Knowledge of primary care doctors about laryngopharyngeal reflux disease.

M S Chorti1, E P Prokopakis, V A Lahanas, Z Bessas, Y Papadakis, S G Velegrakis, Y Papagiannis, T Kaffes.   

Abstract

OBJECTIVES: Many patients with reflux disease present with atypical symptoms (globus pharyngeus, constant throat clearing, chronic cough, hoarseness, catarrh, dysphagia, halitosis, choking episodes, or asthma-like symptoms) due to laryngopharyngeal reflux (LPR). Because such patients can be easily misdiagnosed, doctors in primary care should be aware of LPR and its proper treatment. This study aimed to determine whether doctors working in the primary care setting are aware of the atypical manifestations of reflux and the differences in treatment between LPR and gastroesophageal reflux disease (GERD).
METHODOLOGY: This study was conducted among primary care doctors referring to the Ear, Nose, and Throat department of Karditsa (Greece) General Hospital. A questionnaire regarding the clinical manifestation and treatment of GERD and LPR was supplied to 60 doctors working in the primary care setting of Karditsa prefecture.
RESULTS: Fifty-one doctors returned the questionnaire. Twenty-three (45%) were acquainted with the entity of LPR and 8 (15.7%) were acquainted with the Reflux Symptom Index (RSI). The most common symptoms, for which proton pump inhibitors (PPIs) were prescribed, were: heartburn (76.5%), heartburn combined with other symptoms (17.6%), halitosis (1.96%), hoarseness (1.96%), and choking episodes (1.96%). Most of the surveyed doctors prescribed PPIs for fewer than 12 weeks (92%), once daily (70.6%), and preferably in the morning (50%). Forty-seven (92%) provided advice regarding lifestyle modifications.
CONCLUSION: The majority of surveyed doctors were unaware of LPR or the RSI. More awareness is required in the primary care setting to recognize LPR early and treat it properly.

Entities:  

Mesh:

Year:  2013        PMID: 23641591

Source DB:  PubMed          Journal:  B-ENT        ISSN: 1781-782X            Impact factor:   0.082


  2 in total

1.  Halitosis associated volatile sulphur compound levels in patients with laryngopharyngeal reflux.

Authors:  Mehmet Ozgur Avincsal; Aytug Altundag; Seckin Ulusoy; Mehmet Emre Dinc; Abdullah Dalgic; Murat Topak
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-05       Impact factor: 2.503

2.  Awareness and daily practices of family physicians and trainees towards laryngopharyngeal reflux.

Authors:  Aylin Eryilmaz; Yesim Basal; Ceren Gunel; Sema Basak; Mevlut Ture; Hakan Elatik; Okay Basak
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-07-04       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.